6ML vs ADXN: Side-by-Side Comparison
Compare MOLECULAR PARTNERS SF 1 (6ML) and Addex Therapeutics Ltd (ADXN) side by side: market cap EUR 126.79M vs USD 7.33M. Financials, growth and model signals on Bullrun.
| Metric | 6ML | ADXN |
|---|---|---|
| Company | MOLECULAR PARTNERS SF 1 | Addex Therapeutics Ltd |
| Country / Exchange | Switzerland · F | Switzerland · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | EUR 126.79M | USD 7.33M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (latest FY) | — | — |
| Revenue growth YoY | — | — |
| Net income | — | — |
| Gross margin | — | — |
| Diluted EPS | — | — |